Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 6.90T | 6.76T | 6.57T | 6.22T | 5.63T | 6.19T |
Gross Profit | 3.63T | 3.54T | 3.33T | 3.27T | 2.87T | 2.70T |
EBITDA | 869.71B | 1.47T | 1.53T | -47.75B | 6.21T | 109.78B |
Net Income | 75.69B | -227.65B | -970.14B | -1.71T | 4.99T | -961.58B |
Balance Sheet | ||||||
Total Assets | 47.83T | 46.72T | 43.94T | 47.54T | 45.75T | 37.26T |
Cash, Cash Equivalents and Short-Term Investments | 5.50T | 6.19T | 7.30T | 6.09T | 7.80T | 3.68T |
Total Debt | 21.60T | 21.36T | 20.32T | 22.32T | 19.55T | 14.27T |
Total Liabilities | 33.63T | 33.49T | 33.29T | 35.84T | 33.79T | 29.88T |
Stockholders Equity | 12.12T | 10.97T | 9.03T | 9.98T | 10.21T | 5.91T |
Cash Flow | ||||||
Free Cash Flow | 209.71B | -372.06B | 107.53B | 1.89T | -89.64B | -114.67B |
Operating Cash Flow | 840.86B | 250.55B | 741.29B | 2.73T | 557.25B | 1.12T |
Investing Cash Flow | -1.72T | -841.46B | 547.58B | -3.02T | -1.47T | -4.29T |
Financing Cash Flow | -907.70B | -606.22B | 191.52B | 602.22B | 2.19T | 2.92T |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | $269.58B | 23.14 | 19.35% | 1.48% | 5.31% | 38.46% | |
76 Outperform | $36.23B | 31.23 | 9.59% | 2.77% | -0.19% | -0.79% | |
76 Outperform | $184.17B | 10.38 | 18.23% | 6.22% | 0.93% | 56.97% | |
71 Outperform | $55.73B | 33.09 | 8.54% | 2.71% | 0.19% | -49.68% | |
69 Neutral | $207.81B | 17.74 | 11.38% | 3.92% | 0.50% | -12.66% | |
61 Neutral | $41.01B | -0.64 | -14.21% | 3.80% | 2.39% | -73.52% | |
58 Neutral | $109.92B | 14.33 | 10.28% | 0.27% | -2.23% | ― |